"renal carcinoma" trang 3 - tải miễn phí từ tailieuXANH
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry
8    82    0
Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/ G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/ G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
17    76    0
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
10    136    0
Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
7    104    0
An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma

An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma
10    95    0
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy
10    98    0
Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: A systematic study of 19 immunohistochemical markers in 42 cases

Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: A systematic study of 19 immunohistochemical markers in 42 cases
8    77    0
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study
8    59    0
Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: A case report

Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: A case report
4    64    0
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
9    54    0
Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal

Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
15    50    0
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: A case report and literature review

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: A case report and literature review
6    54    0
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study
11    70    0
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
12    73    0
Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis
9    63    0
Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: A systematic review and meta-analysis

Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: A systematic review and meta-analysis
13    51    0
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2

Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
5    59    0
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
11    63    0
Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines

Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines
8    82    0
Metastatic polyp of the gallbladder from renal cell carcinoma

Metastatic polyp of the gallbladder from renal cell carcinoma
7    46    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.